Cancer Cell Market
- 2026 年市場規模
- USD 12.8 Bn
- 2033 年預估規模
- USD 24.4 Bn
- 年複合成長率 CAGR
- 10.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Cancer Cell Market, By Cancer Cell Type (Carcinomas, Sarcomas, Leukemia, and Others), By Application (Chemotherapy, Radiation Therapy, Immunotherapy, Hormone Therapy, Targeted Drug Therapy, and Others), By End User (Hospitals & Clinics, Specialty Clinics, and Diagnostic Laboratories), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
The global cancer cell market include various therapies used for the treatment of various cancers such as lung cancer, breast cancer, and others. There are various therapies for treatment of cancer such as chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted drug therapy and others. The types of cancer such as carcinomas, sarcomas, leukemia, and others are caused due day to day lifestyles, and or more often, caused by carcinogens (cancer causing substances) such as tobacco etc.
Market Dynamics
Key players are focusing on research and development for treatment of cancers such as small cell lung cancer to strengthen their position in the global cancer cell market. For instance, in December 2019, Roche announced that the U.S. Food and Drug Administration (FDA) approved its Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane) for the initial (first-line) treatment of adults with metastatic non-squamous non-small cell lung cancer (NSCLC) with no epidermal growth factor receptor (EGFR) mutations and anaplastic large-cell lymphoma kinase (ALK) genomic tumor aberrations.
Key features of the study
• This report studies the current scenario as well as the future potential of the global cancer cell market. The market for cancer cell market is segmented on basis of cancer cell type, application, end user, and region.
• This report provides in-depth analysis of the global cancer cell market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2026-2033)
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
• It profiles leading players in the global cancer cell market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
• The global cancer cell market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
• Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global cancer cell market
Market Segmentation
• By Cancer Cell Type (Revenue, USD Bn, 2021-2033)
o Carcinomas
o Sarcomas
o Leukemia
o Others
• By Application (Revenue, USD Bn, 2021-2033)
o Chemotherapy
o Radiation Therapy
o Immunotherapy
o Hormone Therapy
o Targeted Drug Therapy
o Others
• By End User (Revenue, USD Bn, 2021-2033)
o Hospitals & Clinics
o Specialty Clinics
o Diagnostic Laboratories
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Abbott Laboratories
o Novartis International AG
o Arcellx
o Autolus Therapeutics
o Kite Pharma
o Cellectis
o Celyad Oncology
o Crescendo Biologics Limited
o GammaDelta Therapeutics Ltd.
o Bio-Rad Laboratories Inc
o QIAGEN Inc
o Thermo Fisher Scientific
o Merck Millipore
o Siemens Healthineers AG
o GE Healthcare
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Cancer Cell Type
Market Snapshot, By Application
Market Snapshot, By End User
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Drivers
o Restraints
o Opportunities
o Impact Analysis
o Key Developments
o New Product Launches/Approvals
o Merger-Acquisition Scenario
o Regulatory Scenario
o Pipeline Analysis
o Epidemiology
o PEST Analysis
o Reimbursement
4. Global Cancer Cell Market, By Cancer Cell Type, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, 2026, and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Carcinomas
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Sarcomas
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Leukemia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Cancer Cell Market, By Application, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, 2026, and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Chemotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Radiation Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Hormone Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Targeted Drug Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Cancer Cell Market, By End User, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, 2026, and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Hospitals & Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Cancer Cell Market, By Region, 2021-2033 (USD Bn)
o Introduction
Market Share Analysis, By Country, 2026, and 2033 (%)
Y-o-Y Growth Analysis, For Countries, 2022-2033
o North America
Introduction
Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Application 2021-2033 (USD Bn)
Market Size and Forecast, By End User, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Application 2021-2033 (USD Bn)
Market Size and Forecast, By End User, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Application 2021-2033 (USD Bn)
Market Size and Forecast, By End User, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Application 2021-2033 (USD Bn)
Market Size and Forecast, By End User, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Application 2021-2033 (USD Bn)
Market Size and Forecast, By End User, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Cancer Cell Type, 2021-2033 (USD Bn)
Market Size and Forecast, By Application 2021-2033 (USD Bn)
Market Size and Forecast, By End User, 2021-2033 (USD Bn)
Market Size and Forecast, By Country, 2021-2033 (USD Bn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Company Profiles
Abbott Laboratories
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novartis International AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Arcellx
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Autolus Therapeutics
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Kite Pharma
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Cellectis
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Celyad Oncology
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Crescendo Biologics Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
GammaDelta Therapeutics Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Bio-Rad Laboratories Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
QIAGEN Inc
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Thermo Fisher Scientific
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Merck Millipore
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Siemens Healthineers AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
GE Healthcare
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們